Patient-rated conversations
patients and caregivers rate real or scripted chats for clarity, tone, trust and usefulness
Acumen gives pharma and digital health teams consented, de-identified patient and caregiver input, plus clinician review, to train and test the AI that talks to patients.
Request a sample datasetSchedule a conversationPatient experience data for AI is input from consented patients and caregivers, reviewed by clinicians, used to train and test patient-facing AI. It includes rated chatbot conversations, plain-language rewrites, preference rankings and persona validation. Acumen delivers it de-identified, documented and ready for training or evaluation.
Patient support assistants answer at 11pm, when the nurse line is closed and the question feels urgent. An answer that is accurate but confusing still fails. It leads to a missed dose, a dropped program or a patient who stops trusting the brand.
Most teams test with internal staff, generic labelers or synthetic patients. As Inizio puts it, synthetic patients don't mind when you misunderstand them. Real ones do. The gap shows up after launch, in drop-off and complaints.
Acumen puts real patients in the loop before launch.
The questions patient services and digital health teams actually lose sleep over:
Internal staff know the brand language too well. Generic labelers don't live with the condition. Synthetic personas agree too easily. None of them tell you what a frightened caregiver hears.
We match every task to consented patients and caregivers by condition, stage of the patient journey and health literacy. Clinicians matched to the therapy area review the same items.
This enables something simulation cannot: AI that sounds right to the people it serves.
Evaluation has moved to rubrics. OpenAI's HealthBench grades multi-turn health conversations, including conversations with laypeople, against rubrics written by 262 physicians. Physicians can judge whether an answer is correct. Only patients can tell you whether it was understood. We give teams four ways to get both right:
patients and caregivers rate real or scripted chats for clarity, tone, trust and usefulness
participants compare two responses and pick the better one, for fine-tuning and RLHF
we test synthetic patient personas against real patients to show where they hold and where they drift
clinicians check accuracy, escalation and adverse event handling, with deeper probing through healthcare AI red teaming
Patient AI moves from internal sign-off to a de-risked, patient-tested process.
Labels update. Programs change. New indications bring new patients. The model changes every release. A one-off study can't keep up. The questions are constant:
Acumen answers them with patient and caregiver data on a recurring cadence, release after release.
Pharma teams now use synthetic patient personas to pressure-test messages before fielding a study (ZoomRx). Industry consensus is that they work best alongside primary research and need validation (Greenbook, Inizio). Used alone, they leave gaps:
Simulation is easy. Lived experience is not.
From anecdotal feedback → patient data built for production.
| Acumen patient experience data | Crowdsourced annotation | In-house testing (staff or advisory board) | |
|---|---|---|---|
| Who provides input | Consented patients and caregivers matched to your population | Generalist workforce | Employees or a small advisory group |
| Lived experience of the condition | Yes, by design | Rarely | Limited to a few voices |
| Rare disease and caregiver reach | Recruited per project | Very limited | Depends on existing relationships |
| Health literacy range | Recruited across literacy levels | Not tracked | Skews high |
| Clinical safety review | Clinicians matched to therapy area | None | Varies |
| Consent and de-identification | Documented per participant | Varies | Your burden |
| Defensible in compliance review | Yes, with consent and review trail | Rarely | Partly |
Regulators now treat training data as evidence. FDA's January 2025 draft guidance on AI-enabled device software asks sponsors to describe how data was collected, cleaned and processed, and to show test data independence and attention to bias. Under the EU AI Act, transparency obligations apply from August 2026. Not every patient assistant is a regulated device, but buyers and reviewers now ask the same questions.
Every item we deliver carries its provenance: participant profile, consent record, health literacy band, clinician reviewer and how disagreements were resolved. We package it with documentation ready for legal, privacy and MLR review.
AI training has moved from cheap generic labeling to expert input (Sacra). For patient-facing AI, the experts include the patients and caregivers themselves. They don't grade on accuracy alone. They grade on whether they felt understood.
Acumen is the expert data layer for training, evaluating and trusting the AI that talks to patients.
Patient experience data for AI is input from consented patients and caregivers, reviewed by clinicians, used to train and test patient-facing AI. It includes rated chatbot conversations, plain-language rewrites, preference rankings, persona validation and patient journey accounts. Acumen delivers it de-identified, documented and in formats ready for training or evaluation.
We recruit patients and caregivers who match your target population. They hold conversations with your assistant or rate transcripts against a rubric covering clarity, tone, trust and whether the answer helped. Clinicians review the same conversations for safety and accuracy. You get scored transcripts, patient comments and a findings report.
Every participant gives informed consent for the specific project before taking part. The consent explains what they will do, how their input will be used to train or test AI, and how it is stored. Participants can withdraw. We keep consent records with the dataset so your legal and compliance teams can review them.
Participants are asked not to share identifying details, and any that appear are removed before data leaves our pipeline. Every item is de-identified, and we follow HIPAA-aligned handling throughout. Security, privacy and data-handling documentation is available for your procurement and compliance review.
Yes. We recruit rare disease patients and caregivers, with timelines scoped to the size of the population. Caregivers often carry the day-to-day reality of a rare condition, so we recruit them as a distinct group, not as a stand-in for patients.
Yes. Credential-checked clinicians matched to the therapy area review outputs for accuracy, safety and escalation: when the assistant should send someone to their doctor, a pharmacist or emergency care, and how it handles possible adverse event mentions.
Synthetic personas help pressure-test messages early. Industry consensus is that they work best alongside primary research and need validation. We supply real patient and caregiver input to build personas, then test persona answers against real people, so you know where a persona holds and where it drifts.
We deliver JSONL, CSV or a custom schema, with metadata on participant profile, health literacy band, clinician review and agreement for every item. Production volumes follow on a recurring cadence.
Last updated November 2026